Monday, August 31, 2026

NASDAQ 100 Over 13% Up In The Last 21 Sessions

ViaNews Editorial Team

February 8, 2023

NASDAQ 100 Over 13% Up In The Last 21 Sessions

(VIANEWS) - NASDAQ 100 (NDX) has been up by 13.73% for the last 21 sessions. At 10:10 EST on Wednesday, 8 February, NASDAQ 100 (NDX) is $12,633.20.

Volume

Today's last reported volume for NASDAQ 100 is 236422444, 92.37% below its average volume of 3101981945.51.

Regarding NASDAQ 100's yearly highs and lows, it's 21% up from its 52-week low and 17.24% down from its 52-week high.

News about

  • According to FXStreet on Monday, 6 February, "Against this backdrop, US 10-year Treasury bond yields remain firmer around 3.55% while the S&P 500 Futures print mild losses by the press time."
  • According to FXStreet on Monday, 6 February, "It's worth noting that the S&P 500 Futures print mild losses and the stocks in the Asia-Pacific region are mildly offered to portray the sour sentiment."
  • According to FXStreet on Monday, 6 February, "Further, the S&P 500 Futures print mild losses and underpin the US Dollar's safe-haven demand."
  • According to MarketWatch on Monday, 6 February, "Ford shares slumped 8% to $13.23 on Friday but have gained 14% this year, outperforming the 8% rise for the S&P 500 ."

More news about NASDAQ 100 (NDX).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com